Integer (NYSE:ITGR) Releases Earnings Results

Integer (NYSE:ITGR) issued its earnings results on Thursday. The medical equipment provider reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.06, Briefing.com reports. The company had revenue of $472.06 million during the quarter, compared to the consensus estimate of $462.73 million. Integer had a return on equity of 12.84% and a net margin of 4.75%.The company’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.43 earnings per share. Integer updated its FY 2026 guidance to 6.290-6.780 EPS.

Here are the key takeaways from Integer’s conference call:

• Integer delivered a strong FY‑2025 beat with sales up 8% reported (6% organic), adjusted EPS up 21%, expanded adjusted operating margin ~76 bps, and repurchased $50M in Q4 while announcing a ~$50M accelerated share repurchase.
• The 2026 outlook was narrowed and includes an expected 3%–4% headwind from three new products (two in electrophysiology, one in neuromodulation) that had lower‑than‑expected market adoption, driving flat to +3% organic sales guidance and near‑term margin pressure (Q1 operating margin down ~200–250 bps year‑over‑year).
• Capital and cash generation remain solid — FY‑2025 free cash flow was $105M, net total debt is ~$1.19B (3.0x trailing EBITDA), management reaffirmed disciplined capital allocation with continued M&A and buybacks and expects 2026 free cash flow of $100M–$120M.
• Management highlights a diversified, high‑value pipeline (about 40 CRM&N development customers) and expects PMA‑related customers to grow ~15%–20% CAGR over 3–5 years and aims to return to 200 bps above‑market organic growth with margin expansion by 2027, though this is forward‑looking and contingent on product launches.

Integer Price Performance

NYSE:ITGR traded up $1.93 during trading hours on Thursday, reaching $88.41. 950,466 shares of the company’s stock were exchanged, compared to its average volume of 750,851. The company has a quick ratio of 2.45, a current ratio of 3.71 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $3.10 billion, a P/E ratio of 36.79, a price-to-earnings-growth ratio of 0.81 and a beta of 0.77. Integer has a 12 month low of $62.00 and a 12 month high of $144.76. The business’s 50-day simple moving average is $82.37 and its two-hundred day simple moving average is $88.44.

Integer announced that its Board of Directors has authorized a share buyback plan on Tuesday, November 4th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to repurchase up to 8.3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its shares are undervalued.

Institutional Trading of Integer

Several institutional investors and hedge funds have recently bought and sold shares of ITGR. Parkside Financial Bank & Trust raised its stake in Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 267 shares during the period. Arax Advisory Partners grew its position in Integer by 2,489.5% during the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 473 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Integer by 210.5% in the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after acquiring an additional 362 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its position in Integer by 861.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 620 shares during the last quarter. Finally, State of Wyoming raised its position in Integer by 434.2% during the fourth quarter. State of Wyoming now owns 1,608 shares of the medical equipment provider’s stock valued at $126,000 after acquiring an additional 1,307 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer News Summary

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 earnings beat — Integer reported $1.76 EPS vs. the Zacks/consensus $1.70 estimate and up from $1.43 a year ago, showing margin/earnings improvement. Integer (ITGR) Surpasses Q4 Earnings and Revenue Estimates
• Positive Sentiment: Revenue and full-year performance — Q4 revenue rose ~5% YoY; full-year 2025 delivered ~8% sales growth and ~21% adjusted EPS growth, which supports the bullish reaction. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Positive Sentiment: Guidance largely in line to slightly above consensus — FY2026 EPS guidance of $6.29–$6.78 and revenue guidance of $1.8–$1.9B maintains the company’s prior outlook (management highlights keeping the midpoint of sales growth and the high end of adjusted EPS growth). That stability helped investor confidence. Integer FY2026 Guidance and Outlook
• Neutral Sentiment: Guidance nuance — the EPS range’s lower bound (6.29) is marginally below some consensus points (~6.31) while the high end is well above; investors will watch quarterly cadence and margin drivers to judge whether the company hits the high end. Integer Q4 Earnings: Key Metrics Versus Estimates
• Neutral Sentiment: Management materials available — the company posted a press release, slide deck and conference-call transcript for deeper detail; active investors should review the call/slides for margin, backlog and expected product/customer contributions. Listen to Conference Call / View Slide Deck

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $80.00 price target (down previously from $132.00) on shares of Integer in a research note on Friday, October 24th. Argus lowered Integer from a “buy” rating to a “hold” rating in a research report on Friday, October 24th. Piper Sandler dropped their price target on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Bank of America lowered shares of Integer from a “buy” rating to a “neutral” rating and set a $87.00 price objective for the company. in a report on Friday, October 24th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $95.00 price target (down from $143.00) on shares of Integer in a research note on Friday, October 24th. Four research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Integer has an average rating of “Hold” and a consensus price target of $98.38.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.